Pharmaceuticals

Tirzepatide

Evidence: Strong (FDA-approved)

Mechanism of Action

Dual GIP/GLP-1 receptor agonist. Enhances insulin secretion, reduces glucagon, slows gastric emptying, and acts on hypothalamic appetite centers. Produces greater weight loss than semaglutide in head-to-head trials. Also improves cardiovascular risk markers.

Interactions

  • Delays absorption of oral medications
  • Potentiates insulin/sulfonylurea hypoglycemia
  • May affect oral contraceptive absorption

Contraindications

  • Personal/family history of medullary thyroid carcinoma
  • MEN2 syndrome
  • Pancreatitis history
  • Severe GI disease

Key Papers

  • Jastreboff et al. 2022 - SURMOUNT-1 trial (NEJM)

Buy Tirzepatide

If you want to source it today, here’s a fast Amazon search link (we may earn a small commission at no extra cost).

Search on Amazon →
Disclaimer: This information is for educational purposes only and is not medical advice. BioAccelera Labs does not diagnose, treat, or prescribe. Consult a licensed healthcare provider before using any compound.

Should Tirzepatide Be in Your Stack?

Take the free assessment and get personalized recommendations based on your biology and goals.

Get Your Free Protocolor take the assessment →
← Browse All 231 Compounds